[Central nervous system involvement in parasitic tropical diseases].
D000328:Adult; D001812:Blood-Brain Barrier; D002493:Central Nervous System Diseases / Q000209:etiology*; D003551:Cysticercosis / Q000150:complications; D005260:Female; D006249:Hartmannella / Q000302:isolation & purification; D006801:Humans; D006826:Hycanthone / Q000627:therapeutic use; D008288:Malaria / Q000469:parasitology; D008590:Meningoencephalitis / Q000469:parasitology; D009560:Niridazole / Q000627:therapeutic use; D009583:Nitrofurazone / Q000627:therapeutic use; D010272:Parasitic Diseases / Q000150:complications*; D010419:Pentamidine / Q000627:therapeutic use; D010963:Plasmodium falciparum / Q000302:isolation & purification; D010965:Plasmodium malariae / Q000302:isolation & purification; D012552:Schistosomiasis / Q000188:drug therapy / Q000469:parasitology; D014123:Toxoplasmosis / Q000150:complications; D014195:Travel; D014236:Trichlorfon / Q000627:therapeutic use; D014329:Tropical Climate; D014352:Trypanosomiasis / Q000188:drug therapy; D014717:Vertigo / Q000209:etiology; D014944:World Health Organization
D006826:Hycanthone; D010419:Pentamidine; D014236:Trichlorfon; D009560:Niridazole; D009583:Nitrofurazone
ZNS-Befall bei parasitären Tropenkrankheiten.